Izastobart Biosimilar - Research Grade

Human

C5AR1ï؟½

5mg/ml

IgG1 - lambda2

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

P21730

Blue ice

The complement C5a receptor (C5AR1) transmits potent chemotactic and pro-inflammatory signals that shape innate immune responses. This unconjugated, non-therapeutic analog of izastobart is a recombinant human IgG1, lambda monoclonal against the human receptor, made available for research use only (RUO). Held to a low-endotoxin specification for in vivo compatibility, it is produced in scalable milligram to gram batches tailored to high-throughput and bulk laboratories. Typical uses include receptor-antagonism and neutralization assays, chemotaxis studies, in vitro screening, and preclinical inflammation models, where the antibody acts as a stable functional control supporting complement biology and biologics-characterization research.

C5A, C5AR, C5R1, CD88, complement component 5a receptor 1, C5a receptor, complement C5a receptor 1

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks